Human Insulin Market - Global Study on Human Insulin Industry : Asia Pacific to Witness fastest Growth by 2020
Persistence Market Research
Human Insulin Market Will Reach US$49,197.3 million in 2020: Persistence Market Research
Persistence Market Research
1
Human Insulin Market - Global Study on Human Insulin Industry : Asia Pacific to Witness fastest Growth by 2020 Persistence Market Research Released New Market Report “Global Market Study on Human Insulin: Asia Pacific to Witness fastest Growth by 2020,� the global human insulin market was valued at USD 24,332.6 million in 2014 and was expected to grow at a CAGR of 12.4% from 2014 to 2020, to reach an estimated value of USD 49,197.3 million in 2020. Browse the full Global Market Study on Human Insulin: Asia Pacific to Witness fastest Growth by
2020
report
at
http://www.persistencemarketresearch.com/market-
research/human-insulin-market.asp Globally, the human insulin market is witnessing significant growth due to increasing prevalence of diabetes and increasing awareness among people about diabetes care. In addition, technological advancements in insulin delivery devices and increasing prevalence of lifestyle related disorders such as obesity are also driving the growth of the market. However, uneven pricing and limited access to human insulin in emerging countries such as Brazil, India, and China are inhibiting the growth of the human insulin market. In addition, strict regulatory requirements for drug approval are also restraining the growth of the market. The global human insulin market was anticipated to grow from an estimated USD 24,332.6 million in 2014 to USD 49,197.3 million in 2020 at a CAGR of 12.4% during the forecast period. In North America, increasing prevalence of diabetes with growing age and availability of advanced human insulin infusion devices are driving the use of human insulin in the market. In addition, increasing prevalence of lifestyle associated disorders such as obesity is also boosting the growth of the human insulin market in this region. For instance, according to the Centers for Diseases Control and Prevention (CDC), a U.S.-based national public health institute, over one-third children and adolescents were obese in 2012 in the U.S. In Europe, the human insulin market is driven by rising aging population and increasing prevalence of diabetes. In addition, in Germany the market is evolving due to rising prevalence of diabetes and increasing awareness among people about diabetes care. However, in AsiaPacific the growth for human insulin is much higher than developed countries due to increasing prevalence of diabetes and increasing government initiatives for improving healthcare. Novo Nordisk A/S, Eli Lilly and Company, Sanofi, Biocon, Tonghua Dongbao Pharmaceutical Co., Ltd., Adocia, Merck & Co., Inc., Pfizer, Inc., Wockhardt, Julphar, Bristol-Myers Squibb Company, GlaxoSmithKline Plc and Oramed Pharmaceuticals, Inc. are some of the major players in human insulin market.
Persistence Market Research
2
Human Insulin Market - Global Study on Human Insulin Industry : Asia Pacific to Witness fastest Growth by 2020
The human insulin market is segmented as follows: Human insulin market, by type •
Traditional human insulin
•
Modern human insulin
Traditional human insulin market, by type •
Short acting human insulin
•
Intermediate acting human insulin
•
Premixed human insulin
Modern human insulin market, by type •
Rapid-acting human insulin
•
Long-acting human insulin
•
Premixed human insulin
Human insulin market, by disease •
Type 1 diabetes
•
Type 2 diabetes
Traditional human insulin market, by brand •
Humulin
•
Insuman
•
Others
Modern human insulin market, by brand •
Lantus
•
Novolog
•
Humalog
•
Levemir
Persistence Market Research
3
Human Insulin Market - Global Study on Human Insulin Industry : Asia Pacific to Witness fastest Growth by 2020
•
Novomix
•
Apidra
•
Others
Human insulin market, by geography •
•
•
•
North America •
The U.S.
•
Canada
Europe •
Germany
•
France
•
The U.K.
Asia-Pacific •
Japan
•
China
•
India
Rest of the World (RoW)
Market History: Globally, the human insulin market is witnessing significant growth due to increasing prevalence of diabetes and obesity. In addition, increasing R&D investments in drug discovery and development and rising awareness about diabetes are also driving the growth of the market. However, uneven pricing and limited access to human insulin in emerging countries and strict regulatory requirement for drug approval inhibits the growth of the market. The global human insulin market was anticipated to grow from an estimated USD 24,332.6 million in 2014 to USD 49,197.3 million by 2020 at a CAGR of 12.4% during the forecast period. North America has the largest market and Asia-Pacific has the fastest growing market for human insulin. In terms of type of human insulin, modern human insulin represents the largest and fastest growing segment of this market. Modern human insulin provides effective results compare to traditional human insulin. Dosages and duration of modern human insulin vary from person to person, as insulin requirement differs from person
Persistence Market Research
4
Human Insulin Market - Global Study on Human Insulin Industry : Asia Pacific to Witness fastest Growth by 2020 to person. Modern human insulin was estimated at USD 19,526.8 million in 2014 and was expected to reach USD 40,987.1 million by 2020, growing at a CAGR of 13.2% during the forecast period. Some of the major players in the human insulin market are Novo Nordisk A/S, Eli Lilly and Company, Sanofi, Biocon, Tonghua Dongbao Pharmaceutical Co., Ltd., Adocia, Merck & Co., Inc., Pfizer, Inc., Wockhardt and others.
Table of Content Chapter 1 Preface 1.1 Report Description 1.2 Research Methodology 1.3 Assumptions Chapter 2 Market Synopsis Chapter 3 Porter’s Five Forces Analysis 3.1 Bargaining Power of Suppliers 3.2 Bargaining Power of Buyers 3.3 Threat of New Entrants 3.4 Threat of Substitutes 3.5 Intensity of Rivalry Persistence Market Research
5
Human Insulin Market - Global Study on Human Insulin Industry : Asia Pacific to Witness fastest Growth by 2020
Chapter 4 Industry Overview 4.1 Market Definition 4.2 Market Drivers 4.2.1 Growing prevalence of diabetes 4.2.2 Technological advancements in human insulin delivery devices 4.2.3 Increasing awareness among people towards diabetes care 4.3 Impact Analysis of Market Drivers 4.4 Market Restraints 4.4.1 Uneven pricing and limited access to human insulin in emerging countries 4.4.2 Strict regulatory requirements for drug approval 4.5 Impact Analysis of Market Restraints 4.6 Market Trends 4.6.1 Increasing usage of insulin pens for administration of human insulin Chapter 5 Global Market Size and Forecast Chapter 6 Market Size and Forecast by Type 6.1 Traditional Human Insulin 6.2 Modern Human Insulin Chapter 7 Market Size and Forecast of Traditional Human Insulin by Type 7.1 Short-acting Human Insulin 7.2 Intermediate-acting Human Insulin 7.3 Premixed Human Insulin Chapter 8 Market Size and Forecast of Modern Human Insulin by Type 8.1 Rapid-acting Human Insulin 8.2 Long-acting Human Insulin 8.3 Premixed Human Insulin Chapter 9 Market Size and Forecast by Disease
Persistence Market Research
6
Human Insulin Market - Global Study on Human Insulin Industry : Asia Pacific to Witness fastest Growth by 2020 9.1 Type 1 Diabetes 9.2 Type 2 Diabetes Chapter 10 Market Size and Forecast by Brand 10.1 Traditional Human Insulin Brand 10.2 Modern Human Insulin Brand Chapter 11 Market Size and Forecast by Geography 11.1 North America 11.1.1 Scenario in the U.S. 11.1.2 Scenario in Canada 11.2 Europe 11.2.1 Scenario in Germany 11.2.2 Scenario in France 11.2.3 Scenario in the U.K. 11.3 Asia Pacific 11.3.1 Scenario in Japan 11.3.2 Scenario in China 11.3.3 Scenario in India Chapter 12 Pipeline Drugs for Diabetes Treatment 12.1 Drugs Under Development for Diabetes Treatment Chapter 13 Competitive Scenario 13.1 Competitive Benchmarking Chapter 14 Company Profiles 14.1 Novo Nordisk A/S 14.1.1 Company overview 14.1.2 Products and services 14.1.3 Financial performance 14.1.4 Key developments
Persistence Market Research
7
Human Insulin Market - Global Study on Human Insulin Industry : Asia Pacific to Witness fastest Growth by 2020 14.2 Eli Lilly and Company 14.2.1 Company overview 14.2.2 Products and services 14.2.3 Financial performance 14.2.4 Key developments 14.3 Sanofi 14.3.1 Company overview 14.3.2 Products and services 14.3.3 Financial performance 14.3.4 Key developments 14.4 Biocon 14.4.1 Company overview 14.4.2 Products and services 14.4.3 Financial performance 14.4.4 Key developments 14.5 Tonghua Dongbao Pharmaceutical Co., Ltd. 14.5.1 Company overview 14.5.2 Products and services 14.5.3 Financial performance 14.5.4 Key developments 14.6 ADOCIA 14.6.1 Company overview 14.6.2 Products and services 14.6.3 Financial performance 14.6.4 Key developments 14.7 Wockhardt 14.7.1 Company overview 14.7.2 Products and services 14.7.3 Financial performance 14.7.4 Key developments 14.8 Julphar 14.8.1 Company overview
Persistence Market Research
8
Human Insulin Market - Global Study on Human Insulin Industry : Asia Pacific to Witness fastest Growth by 2020 14.8.2 Products and services 14.8.3 Financial performance 14.8.4 Key developments 14.9 Merck & Co., Inc. 14.9.1 Company overview 14.9.2 Products and services 14.9.3 Financial performance 14.9.4 Key developments 14.10 Pfizer, Inc. 14.10.1 Company overview 14.10.2 Products and services 14.10.3 Financial performance 14.10.4 Key developments 14.11 Bristol-Myers Squibb Company 14.11.1 Company overview 14.11.2 Products and services 14.11.3 Financial performance 14.11.4 Key developments 14.12 GlaxoSmithKline Plc 14.12.1 Company overview 14.12.2 Products and services 14.12.3 Financial performance 14.12.4 Key developments 14.13 Oramed Pharmaceuticals, Inc. 14.13.1 Company overview 14.13.2 Products and services 14.13.3 Financial performance 14.13.4 Key developments
Persistence Market Research
9
Human Insulin Market - Global Study on Human Insulin Industry : Asia Pacific to Witness fastest Growth by 2020
List of Tables TABLE 1 Market snapshot: Human insulin market, 2014 and 2020 TABLE 2 Drivers for human insulin market: Impact analysis TABLE 3 Restraints for human insulin market: Impact analysis TABLE 4 Global human insulin market size, by region, 2010 – 2013 (USD million) TABLE 5 Global human insulin market size, by region, 2014 – 2020 (USD million) TABLE 6 Global human insulin market size, by type, 2010 – 2013 (USD million) TABLE 7 Global human insulin market size, by type, 2014 – 2020 (USD million) TABLE 8 Global traditional human insulin market size, by region, 2010 – 2013 (USD million) TABLE 9 Global traditional human insulin market size, by region, 2014 – 2020 (USD million) TABLE 10 Global modern human insulin market size, by region, 2010 – 2013 (USD million) TABLE 11 Global modern human insulin market size, by region, 2014 – 2020 (USD million) TABLE 12 Global short-acting human insulin market size, by region, 2010 – 2013 (USD million) TABLE 13 Global short-acting human insulin market size, by region, 2014 – 2020 (USD million) TABLE 14 Global intermediate-acting human insulin market size, by region, 2010 – 2013 (USD million) TABLE 15 Global intermediate-acting human insulin market size, by region, 2014 – 2020 (USD million) TABLE 16 Global premixed human insulin market size, by region, 2010 – 2013 (USD million) TABLE 17 Global premixed human insulin market size, by region, 2014 – 2020 (USD million) TABLE 18 Global rapid-acting human insulin market size, by region, 2010 – 2013 (USD million) TABLE 19 Global rapid-acting human insulin market size, by region, 2014 – 2020 (USD million) TABLE 20 Global long-acting human insulin market size, by region, 2010 – 2013 (USD million) TABLE 21 Global long-acting human insulin market size, by region, 2014 – 2020 (USD million) TABLE 22 Global premixed human insulin market size, by region, 2010 – 2013 (USD million) TABLE 23 Global premixed human insulin market size, by region, 2014 – 2020 (USD million) TABLE 24 Global type 1 diabetes human insulin market size, by region, 2010 – 2013 (USD million) TABLE 25 Global type 1 diabetes human insulin market size, by region, 2014 – 2020 (USD million)
Persistence Market Research
10
Human Insulin Market - Global Study on Human Insulin Industry : Asia Pacific to Witness fastest Growth by 2020 TABLE 26 Global type 2 diabetes human insulin market size, by region, 2010 – 2013 (USD million) TABLE 27 Global type 2 diabetes human insulin market size, by region, 2014 – 2020 (USD million) TABLE 28 Global traditional human insulin market size, by brand, 2010 – 2013 (USD million) TABLE 29 Global traditional human insulin market size, by brand, 2014 – 2020 (USD million) TABLE 30 Global modern human insulin market size, by brand, 2010 – 2013 (USD million) TABLE 31 Global modern human insulin market size, by brand, 2014 – 2020 (USD million) TABLE 32 The North American human insulin market size, by country, 2010 – 2013 (USD million) TABLE 33 The North American human insulin market size, by country, 2014 – 2020 (USD million) TABLE 34 The U.S. human insulin market size, by type, 2010 – 2013 (USD million) TABLE 35 The U.S. human insulin market size, by type, 2014 – 2020 (USD million) TABLE 36 The U.S. traditional human insulin market size, by type, 2010 – 2013 (USD million) TABLE 37 The U.S. traditional human insulin market size, by type, 2014 – 2020 (USD million) TABLE 38 The U.S. modern human insulin market size, by type, 2010 – 2013 (USD million) TABLE 39 The U.S. modern human insulin market size, by type, 2014 – 2020 (USD million) TABLE 40 The Canadian human insulin market size, by type, 2010 – 2013 (USD million) TABLE 41 The Canadian human insulin market size, by type, 2014 – 2020 (USD million) TABLE 42 The Canadian traditional human insulin market size, by type, 2010 – 2013 (USD million) TABLE 43 The Canadian traditional human insulin market size, by type, 2014 – 2020 (USD million) TABLE 44 The Canadian modern human insulin market size, by type, 2010 – 2013 (USD million) TABLE 45 The Canadian modern human insulin market size, by type, 2014 – 2020 (USD million) TABLE 46 The European human insulin market size, by country, 2010 – 2013 (USD million) TABLE 47 The European human insulin market size, by country, 2014 – 2020 (USD million) TABLE 48 The German human insulin market size, by type, 2010 – 2013 (USD million) TABLE 49 The German human insulin market size, by type, 2014 – 2020 (USD million)
Persistence Market Research
11
Human Insulin Market - Global Study on Human Insulin Industry : Asia Pacific to Witness fastest Growth by 2020 TABLE 50 The German traditional human insulin market size, by type, 2010 – 2013 (USD million) TABLE 51 The German traditional human insulin market size, by type, 2014 – 2020 (USD million) TABLE 52 The German modern human insulin market size, by type, 2010 – 2013 (USD million) TABLE 53 The German modern human insulin market size, by type, 2014 – 2020 (USD million) TABLE 54 The French human insulin market size, by type, 2010 – 2013 (USD million) TABLE 55 The French human insulin market size, by type, 2014 – 2020 (USD million) TABLE 56 The French traditional human insulin market size, by type, 2010 – 2013 (USD million) TABLE 57 The French traditional human insulin market size, by type, 2014 – 2020 (USD million) TABLE 58 The French modern human insulin market size, by type, 2010 – 2013 (USD million) TABLE 59 The French modern human insulin market size, by type, 2014 – 2020 (USD million) TABLE 60 The U.K. human insulin market size, by type, 2010 – 2013 (USD million) TABLE 61 The U.K. human insulin market size, by type, 2014 – 2020 (USD million) TABLE 62 The U.K. traditional human insulin market size, by type, 2010 – 2013 (USD million) TABLE 63 The U.K. traditional human insulin market size, by type, 2014 – 2020 (USD million) TABLE 64 The U.K. modern human insulin market size, by type, 2010 – 2013 (USD million) TABLE 65 The U.K. modern human insulin market size, by type, 2014 – 2020 (USD million) TABLE 66 The Asia Pacific human insulin market size, by country, 2010 – 2013 (USD million) TABLE 67 The Asia Pacific human insulin market size, by country, 2014 – 2020 (USD million) TABLE 68 The Japanese human insulin market size, by type, 2010 – 2013 (USD million) TABLE 69 The Japanese human insulin market size, by type, 2014 – 2020 (USD million) TABLE 70 The Japanese traditional human insulin market size, by type, 2010 – 2013 (USD million) TABLE 71 The Japanese traditional human insulin market size, by type, 2014 – 2020 (USD million) TABLE 72 The Japanese modern human insulin market size, by type, 2010 – 2013 (USD million) TABLE 73 The Japanese modern human insulin market size, by type, 2014 – 2020 (USD million) TABLE 74 The Chinese human insulin market size, by type, 2010 – 2013 (USD million) TABLE 75 The Chinese human insulin market size, by type, 2014 – 2020 (USD million)
Persistence Market Research
12
Human Insulin Market - Global Study on Human Insulin Industry : Asia Pacific to Witness fastest Growth by 2020 TABLE 76 The Chinese traditional human insulin market size, by type, 2010 – 2013 (USD million) TABLE 77 The Chinese traditional human insulin market size, by type, 2014 – 2020 (USD million) TABLE 78 The Chinese modern human insulin market size, by type, 2010 – 2013 (USD million) TABLE 79 The Chinese modern human insulin market size, by type, 2014 – 2020 (USD million) TABLE 80 The Indian human insulin market size, by type, 2010 – 2013 (USD million) TABLE 81 The Indian human insulin market size, by type, 2014 – 2020 (USD million) TABLE 82 The Indian traditional human insulin market size, by type, 2010 – 2013 (USD million) TABLE 83 The Indian traditional human insulin market size, by type, 2014 – 2020 (USD million) TABLE 84 The Indian modern human insulin market size, by type, 2010 – 2013 (USD million) TABLE 85 The Indian modern human insulin market size, by type, 2014 – 2020 (USD million) TABLE 86 Major pipeline drugs for diabetes treatment TABLE 87 Major product segments of Novo Nordisk A/S TABLE 88 Major product segments of Eli Lilly and Company TABLE 89 Major product categories of Sanofi TABLE 90 Major product categories of Biocon TABLE 91 Major product categories of Tonghua Dongbao Pharmaceutical Co., Ltd. TABLE 92 Major product categories of Adocia TABLE 93 Major product categories of Wockhardt TABLE 94 Major product categories of Julphar TABLE 95 Major product categories of Merck & Co., Inc. TABLE 96 Major product categories of Pfizer, Inc. TABLE 97 Major product categories of Bristol-Myers Squibb Company TABLE 98 Major product categories of GlaxoSmithKline Plc TABLE 99 Major product categories of Oramed Pharmaceuticals, Inc. List of Figures FIG. 1 Human insulin market: Porter’s five forces analysis FIG. 1 Major types of human insulin FIG. 2 Major types of insulin delivery devices
Persistence Market Research
13
Human Insulin Market - Global Study on Human Insulin Industry : Asia Pacific to Witness fastest Growth by 2020 FIG. 3 Number of people with diabetes mellitus (20 – 79 years) in major countries, 2010 and 2030 (million) FIG. 4 Prevalence of overweight and obese males aged 30 years and above, 2005 and 2015 (%) FIG. 5 Prevalence of overweight and obese females aged 30 years and above, 2005 and 2015 (%) FIG. 6 Global human insulin market share, by region, by value, 2013 FIG. 7 Global human insulin market share, by type, by value, 2013 FIG. 8 Global traditional human insulin market share, by region, by value, 2013 FIG. 9 Global modern human insulin market share, by region, by value, 2013 FIG. 10 Global short-acting human insulin market share, by region, by value, 2013 FIG. 11 Global intermediate-acting human insulin market share, by region, by value, 2013 FIG. 12 Global premixed human insulin market share, by region, by value, 2013 FIG. 13 Global rapid-acting human insulin market share, by region, by value, 2013 FIG. 14 Global long-acting human insulin market share, by region, by value, 2013 FIG. 15 Global premixed human insulin market share, by region, by value, 2013 FIG. 16 Global type 1 diabetes human insulin market share, by region, by value, 2013 FIG. 17 Global type 2 diabetes human insulin market share, by region, by value, 2013 FIG. 18 Global traditional human insulin market share, by brand, by value, 2013 FIG. 19 Global modern human insulin market share, by brand, by value, 2013 FIG. 20 The North American human insulin market share, by country, by value, 2013 FIG. 21 The U.S. human insulin market share, by type, by value, 2013 FIG. 22 The U.S. traditional human insulin market share, by type, by value, 2013 FIG. 23 The U.S. modern human insulin market share, by type, by value, 2013 FIG. 24 The Canadian human insulin market share, by type, by value, 2013 FIG. 25 The Canadian traditional human insulin market share, by type, by value, 2013 FIG. 26 The Canadian modern human insulin market share, by type, by value, 2013 FIG. 27 The European human insulin market share, by country, by value, 2013 FIG. 28 The German human insulin market share, by type, by value, 2013 FIG. 29 The German traditional human insulin market share, by type, by value, 2013 FIG. 30 The German modern human insulin market share, by type, by value, 2013 FIG. 31 The French human insulin market share, by type, by value, 2013
Persistence Market Research
14
Human Insulin Market - Global Study on Human Insulin Industry : Asia Pacific to Witness fastest Growth by 2020 FIG. 32 The French traditional human insulin market share, by type, by value, 2013 FIG. 33 The French modern human insulin market share, by type, by value, 2013 FIG. 34 The U.K. human insulin market share, by type, by value, 2013 FIG. 35 The U.K. traditional human insulin market share, by type, by value, 2013 FIG. 36 The U.K. modern human insulin market share, by type, by value, 2013 FIG. 37 The Asia Pacific human insulin market share, by country, by value, 2013 FIG. 38 The Japanese human insulin market share, by type, by value, 2013 FIG. 39 The Japanese traditional human insulin market share, by type, by value, 2013 FIG. 40 The Japanese modern human insulin market share, by type, by value, 2013 FIG. 41 The Chinese human insulin market share, by type, by value, 2013 FIG. 42 The Chinese traditional human insulin market share, by type, by value, 2013 FIG. 43 The Chinese modern human insulin market share, by type, by value, 2013 FIG. 44 The Indian human insulin market share, by type, by value, 2013 FIG. 45 The Indian traditional human insulin market share, by type, by value, 2013 FIG. 46 The Indian modern human insulin market share, by type, by value, 2013 FIG. 47 Competitive benchmarking of human insulin manufacturing companies FIG. 48 Novo Nordisk’s net sales and net profit, 2011 – 2013 (USD million) FIG. 49 Eli Lilly and Company’s revenue and net income, 2011 – 2013 (USD million) FIG. 50 Sanofi’s net sales and net income, 2011 – 2013 (USD million) FIG. 51 Biocon’s revenue and profit, 2012 – 2014 (USD million) FIG. 52 Tonghua Dongbao Pharmaceutical Co., Ltd.’s total revenue and net income, 2011 – 2013 (USD million) FIG. 53 Wockhardt’s revenue and net income, 2011 – 2013 (USD million) FIG. 54 Julphar’s sales and profit, 2011 – 2013 (USD million) FIG. 55 Merck & Co., Inc.’s sales and net income, 2011 – 2013 (USD million) FIG. 56 Pfizer, Inc.’s revenue and net income, 2011 – 2013 (USD million) FIG. 57 Bristol-Myers Squibb Company’s total revenue and net earnings, 2011 – 2013 (USD million) FIG. 58 GlaxoSmithKline Plc’s turnover and profit, 2011 – 2013 (USD million)
Persistence Market Research
15
Human Insulin Market - Global Study on Human Insulin Industry : Asia Pacific to Witness fastest Growth by 2020 About Us: Persistence Market Research is a global market research firm specializing- syndicated research, custom research, and consulting services
At Persistence Market Research (PMR), we are in the business of accelerating your business. As a fullservice market research firm, we stand committed to bringing more accuracy and speed to your business decisions. From ready-to-purchase market research reports to customized global research solutions, our engagement models are highly flexible without compromising on our deep-seated research values. Briefly stated, our mission is to give you access to forecasts and trends analyses that put you on the path to profitability.
PMR’s Services Go Beyond Gleaning Data
Most enterprises believe that IT and databases are enough to make an accurate decision. While we do not dispute that, consider this: How long does it take to make an accurate and strategic million-dollar decision? We strive to deliver both even with demanding deadlines.
Contact Us: Addie Thomes 305 Broadway 7th Floor, New York City, NY 10007, United States, USA - Canada Toll Free: 800-961-0353 Email: sales@persistencemarketresearch.com Web: http://www.persistencemarketresearch.com Twitter: https://twitter.com/addiethomes Blog: http://persistencemarketresearchblog.wordpress.com/
Persistence Market Research
16